EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Hyperferritinemia and inflammation

Kate F Kernan, Joseph A Carcillo

International Immunology · 01.11.2017 · 29 (9) · 401-409

DOI: 10.1093/intimm/dxx031 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunology, online erschienen am 25.05.2017. Verfasst von Kate F Kernan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, University of Pittsburgh, 3550 Terrace Street, Pittsburgh, PA 15261, USA. Hauptthemen laut MEDLINE: Hemochromatosis, Inflammation. Die Arbeit wurde bisher 565-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding of ferritin biology has traditionally centered on its role in iron storage and homeostasis, with low ferritin levels indicative of deficiency and high levels indicative of primary or secondary hemochromatosis. However, further work has shown that iron, redox biology and inflammation are inexorably linked. During infection, increased ferritin levels represent an important host defense mechanism that deprives bacterial growth of iron and protects immune cell function. It may also be protective, limiting the production of free radicals and mediating immunomodulation. Additionally, hyperferritinemia is a key acute-phase reactants, used by clinicians as an indication for therapeutic intervention, aimed at controlling inflammation in high-risk patients. One school of thought maintains that hyperferritinemia is an ‘innocent bystander’ biomarker of uncontrolled inflammation that can be used to gauge effectiveness of intervention. Other schools of thought maintain that ferritin induction could be a protective negative regulatory loop. Others maintain that ferritin is a key mediator of immune dysregulation, especially in extreme hyperferritinemia, via direct immune-suppressive and pro-inflammatory effects. There is a clear need for further investigation of the role of ferritin in uncontrolled inflammatory conditions both as a biomarker and mediator of disease because its occurrence identifies patients with high mortality risk and its resolution predicts their improved survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemochromatosisInflammationAcute-Phase ReactionAnimalsCataractFerritinsHumansImmunity, InnateImmunomodulationIronIron Metabolism Disorders

Stichwörter der Autor:innen

ferritinhemophagocytic lymphohistiocytosishemophagocytosisironmacrophage activation

Substanzen

FerritinsIron

Autor:innen und Institutionen

  • Department of Critical Care Medicine, University of Pittsburgh, 3550 Terrace Street, Pittsburgh, PA 15261, USA.

Förderung

  • National Institute of General Medical Sciences

Zitieren

APA

Kernan, K. F., & Carcillo, J. A. (2017). Hyperferritinemia and inflammation. International Immunology, 29(9), 401-409. https://doi.org/10.1093/intimm/dxx031

Vancouver

Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. International Immunology. 2017;29(9):401-409. doi:10.1093/intimm/dxx031

BibTeX
@article{Kernan2017,
  author = {Kernan, Kate F and Carcillo, Joseph A},
  title = {Hyperferritinemia and inflammation},
  journal = {International Immunology},
  year = {2017},
  volume = {29},
  number = {9},
  pages = {401--409},
  doi = {10.1093/intimm/dxx031}
}
Kostenlos starten →